Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Distribution of Mutations Associated With Congenital Myasthenic Syndromes (CMS): Results From the First 54 Specimens Tested at a Clinical Reference Laboratory

AAAN 2020: American Academy of Neurology Annual Meeting
[in-person conference canceled, but abstracts available online], April 25-May 1, 2020

Distribution of mutations associated with congenital myasthenic syndromes (CMS): results from the first 54 specimens tested at a clinical reference laboratory

Authors: Batish SD, Wang Z, Lebron F, Meservey MA, Radcliff J, Datta V
Disclaimer: One or more of the authors of this publication were employed at the time by Athena Diagnostics, a subsidiary of Quest Diagnostics.

Specialties: genetics, neurology

Download key summary

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.